VIA
VYGR icon

Virtus Investment Advisers’s Voyager Therapeutics VYGR Stock Holding History

Virtus Investment Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,105
Closed -$114K – 695
2024
Q4 		$114K Buy
20,105
+7,457
+59% +$48.1K 0.09% 248
2024
Q3 		$74K Hold
12,648
– – 0.06% 264
2024
Q2 		$100K Hold
12,648
– – 0.08% 239
2024
Q1 		$118K Buy
+12,648
New +$107K 0.08% 234

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Investment Advisers's VYGR Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 20,105 shares — an estimated $114K sold.

Virtus Investment Advisers first reported a position in VYGR in Q1 2024 and held it in 4 quarters. The position peaked at $118K in Q1 2024. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 20,105 Voyager Therapeutics shares in Q1 2025, an estimated $114K.
  • Virtus Investment Advisers first reported a position in Voyager Therapeutics in Q1 2024 and held it in 4 quarters.
  • Virtus Investment Advisers's Voyager Therapeutics position peaked at $118K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.